Transformative research on next-generation needle-free vaccines and therapeutics recognized in Georgia

Micron Biomedical Receives Georgia Life Science Phoenix Award

At an event honoring life science innovation in Georgia, an active CDC clinical trial of Micron Biomedical’s rotavirus vaccine and Lancet-published research on Micron Biomedical’s self-administered influenza vaccine, both conducted at Emory University, were highlighted. The 2026 Phoenix Award is one of the top honors at the Georgia Life Sciences annual Golden Helix Awards recognizing exceptional collaborations between government, academia and industry. Pictured accepting the award on behalf of Micron Biomedical is Sebastien Henry, Co-Founder and Head of Technical Operations (center). Presenting the award (left) is Kendall Brantley, Project Coordinator, Economic Development at the Metro Atlanta Chamber and (right) Maria Thacker Goethe, MPH, President & CEO, Georgia Life Sciences.

Format

PNG

Source

Micron Biomedical

Downloads